1. Contact information for the person discharging managerial responsibilities or the closely related person

Company name: Sartorius AG

Legal form: AG (Aktiengesellschaft)

2. Reason for notification

The declarant is a closely related person referred to in Article 3.26) of EU Regulation 596/2014 of April 16, 2014 on market abuse.

Please specify the positions held within the issuer.

Positions:  i. Joachim Kreuzburg is chairman and CEO of Sartorius Stedim Biotech SA and chairman of the management board of Sartorius AG;

ii. Dr. René Fáber is a member of the board of Sartorius Stedim Biotech SA and a member of the management board of Sartorius AG;

iii. Dr. Lothar Kappich is a member of the board of Sartorius Stedim Biotech SA and chairman of the supervisory board of Sartorius AG.

This is an initial notification.

3. Contact information of the issuer

Company name: Sartorius Stedim Biotech S.A.

LEI: 52990006IVXY7GCSSR39

4. Information about the transaction

Date of the transaction: 02/11/2020

Place of the transaction: outside a trading venue

Nature of the transaction: sale

Description of the financial instrument: shares

Identification code: FR0013154002

Detailed information by transaction:

Unit price: EUR 327.00

Volume: 405,887 shares

Aggregated information:

Weighted average price: EUR 327.00

Volume: 405,887 shares

The transaction is NOT related to the exercise of a stock option program or to a bonus or performance share grant.

5. Comments

Ø